{"result": "(\"entity\"<|>NUTRICIÓN CLÍNICA<|>ORGANIZATION<|>Nutritional clinical practices focus on dietary management and treatment of various health conditions, including the ketogenic diet.)\n##\n(\"entity\"<|>DIETOTERAPIA<|>EVENT<|>Dietotherapy refers to the therapeutic use of diet in the management of health conditions, particularly in clinical settings.)\n##\n(\"entity\"<|>ENDOCINOLOGÍA<|>EVENT<|>Endocrinology is the branch of medicine that deals with the endocrine system, its diseases, and its specific secretions known as hormones.)\n##\n(\"relationship\"<|>NUTRICIÓN CLÍNICA<|>HOSPITAL CLÍNIC<|>Hospital Clínic provides services in clinical nutrition, including dietotherapy and endocrinology<|>7)\n##\n(\"relationship\"<|>PERE LEYES I GARCÍA<|>ENDOCINOLOGÍA<|>Pere Leyes i García specializes in endocrinology, focusing on hormonal and metabolic disorders<|>8)\n##\n(\"relationship\"<|>JOAN TRABAL VÍLCHES<|>NUTRICIÓN CLÍNICA<|>Joan Trabal Vílchez practices clinical nutrition, focusing on dietary management for patients<|>7)\n##\n(\"relationship\"<|>DIETA CETOGÉNICA<|>DIETOTERAPIA<|>The ketogenic diet is a form of dietotherapy used to manage certain medical conditions, including epilepsy<|>6)\n##\n(\"relationship\"<|>ENDOCINOLOGÍA<|>DIETOTERAPIA<|>Endocrinology often involves dietotherapy as part of the treatment for metabolic and hormonal disorders<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Ann Pharmacother 2003; 37:679-82.\n     10:519-521.                                                            39.   Guillem P, Porte H, Triboulet JP. Chylothorax et\n32.  Martínez Brocca MA, García García-Doncel L, Per-                             chyloperitoneum        post-operatoires.       Efficacité   de\n     era Cunill JL, Ortegón Alcalde S, Martino Galiano                            l’etilefrine. J Chir Thor Cardiovasc 1999; 3:70.\n     ML, García Luna PP. Soporte nutricional en el                          40.   Lutz P, Strunk H, Schild HH, Sauerbruch T. Trans-\n     quilotórax secundario a linfoma. Nutr Hosp. 2002;                            jugular intrahepatic portosystemic shunt in refrac-\n     17:43-45.                                                                    tory chylothorax due to liver cirrhosis. World J Gas-\n33.  Sirvent Ochando M, Lopez Villodre P, Martínez Seguí                          troenterol 2013; 19:1140-2\n     MJ. Soporte nutricional y tratamiento con octreotida                   41.   Alejandre-Lafont E, Krompiec C, Rau WS, Krom-\n     del quilotórax. Nutr Hosp 2010; 25:113-119.                                  bach GA. Effectiveness of therapeutic lymphogra-\n34.  Kelly RF, Shumway SJ. Conservative management                                phy   on   lymphatic      leakage.    Acta    Radiol    2011;\n     of postoperative chylothorax using somatostatin.                             52:305-11\n     Ann Thorac Surg 2000; 69:1944-1945.                                    42.   Nadolski GJ, Itkin M. Thoracic duct embolization\n35.  Huang Q, Jiang ZW, Jiang J, Li N, Li JS. Chylous                             for nontraumatic chylous effusion: Experience in\n     ascites: treated with total parenteral nutrition and                         34 patients. Chest 2013; 143:158-63.\n     somatostatin. World J Gastroenterol 2004; 10:                          43.   Itkin M, Kucharrczuk JC, Kwak A, Trerotola SO,\n     2588-2591.                                                                   Kaiser LR. Non-operative thoracic duct emboliza-\n36.  Ferrandiére M, Hazouard E, Guicheteau V, Gou-                                tion for traumatic thoracic duct leak: experience in\n     chet A, Bensenouci M, Lamotte C, Mercier C. Chy-                             109   patients.    J  Thorac     Cardiovasc     Surg    2010;\n     lous ascites following radical nephrectomy: effi-                            139:584-9\n     ciency of octreotide as treatment of a ruptured                        44.   Schild H, Hirner A. Percutaneous translymphatic\n     thoracic duct. Intensive Care 2000; 26: 484-485.                             thoracic duct embolization for treatment of chylo-\n37.  Shapiro AM, Bain VG, Sigalet DL, Kneteman NM.                                thorax. RöFö 2001; 173:580-2\n     Rapid resolution of chylous ascites after transplan-                   45.   Litherland B, Given M, Lyon S. Percutaneous radio-\n     tation using somatostatin analog and total paren-                            logical management of high output chylothorax\n     teral   nutrition.   Transplantation       1996;    61:1410-                 with CT-guided needle disruption. J Med Imaging\n     1411.                                                                        Radiat Oncol 2008; 52:164-7.\n---\nNO_CONTENT_HERE\n---\nTema 22.\nEpilepsia. Dietas cetogénicas\nPere Leyes i García\nEspecialista en Endocrinología y Nutrición. Servicio de Endocrinología y Nutrición. Unidad de Nutrición\ny Dietética Clínica. Hospital Clínic. Barcelona\nJoan Trabal Vílchez\nDietista-Nutricionista. Servicio de Endocrinología y Nutrición. Unidad de Nutrición y Dietética Clínica.\nHospital Clínic. Barcelona\n\n\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 365-376.\n\n\n\n   1.  Introducción\n   2.  Dieta cetogénica\n   3.  Resumen y conclusiones\n   4.  Bibliografía\n\n\n\n1.   Introducción                                                            durante un largo período el grueso de la evidencia\n                                                                             científica se ha basado en grandes estudios observa-\n   El control de la dieta es una de las formas de trata-                     cionales. No obstante, en los últimos años han sido\nmiento más antiguas y más comunes que existen. A lo                          publicados ensayos clínicos\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL CLÍNIC<|>ORGANIZATION<|>Hospital Clínic is a medical institution located in Barcelona, specializing in endocrinology and nutrition.)\n##\n(\"entity\"<|>PERE LEYES I GARCÍA<|>PERSON<|>Pere Leyes i García is a specialist in Endocrinology and Nutrition at Hospital Clínic, Barcelona.)\n##\n(\"entity\"<|>JOAN TRABAL VÍLCHES<|>PERSON<|>Joan Trabal Vílchez is a Dietitian-Nutritionist at Hospital Clínic, Barcelona, working in the Endocrinology and Nutrition department.)\n##\n(\"entity\"<|>DIETA CETOGÉNICA<|>EVENT<|>The ketogenic diet is a dietary treatment that has been studied for its effects on various health conditions, particularly epilepsy.)\n##\n(\"relationship\"<|>PERE LEYES I GARCÍA<|>HOSPITAL CLÍNIC<|>Pere Leyes i García works at Hospital Clínic as a specialist in Endocrinology and Nutrition<|>8)\n##\n(\"relationship\"<|>JOAN TRABAL VÍLCHES<|>HOSPITAL CLÍNIC<|>Joan Trabal Vílchez works at Hospital Clínic as a Dietitian-Nutritionist<|>8)\n##\n(\"relationship\"<|>PERE LEYES I GARCÍA<|>DIETA CETOGÉNICA<|>Pere Leyes i García is involved in the study and application of the ketogenic diet in clinical settings<|>6)\n##\n(\"relationship\"<|>JOAN TRABAL VÍLCHES<|>DIETA CETOGÉNICA<|>Joan Trabal Vílchez is involved in the study and application of the ketogenic diet in clinical settings<|>6)\n<|COMPLETE|>"}]}